Busulfan Injection 60?mg Price comparison
$1.00
Busulfan Injection (brand: Yilai, BaiXiaoAn) is a cytotoxic alkylating agent used for preconditioning in hematopoietic stem cell and chronic myeloid leukemia (CML) research. Supplied as a 60?mg freeze-dried injection in 10?ml vials, 10 vials per box. Manufactured by China Resources Double-Crane Pharmaceutical Co., Ltd., approved under China NMPA H20183147.
?? For laboratory research use only.?Please consult the staff for other purposes?
描述
Product Specifications
| Attribute | Details |
|---|---|
| Product Name | Busulfan Injection (BaiXiaoAn / Yilai) |
| Generic Name | Busulfan (1,4-Butanediol dimethanesulfonate) |
| Dosage Form | Lyophilized injection |
| Strength | 60?mg / 10?ml per vial |
| Pack Size | 10 vials per box |
| Approval Number | H20183147 (China NMPA) |
| Product Code | 86981661000076 |
| Manufacturer | China Resources Double?Crane Pharmaceutical Co., Ltd. |
| Barcode | 6921789020444 |
| Storage | Store at 2–8?°C, protect from moisture |
| Intended Use | Laboratory research only |
Mechanism of Action
Busulfan is an alkyl sulfonate that crosslinks DNA, leading to cell cycle arrest and apoptosis. It is typically used as part of preconditioning regimens in hematopoietic stem cell transplantation for CML models dcpc.com+8zh.wikipedia.org+8pmc.ncbi.nlm.nih.gov+8.
Research Applications & Pharmacology
-
Preconditioning agent: Used with Cyclophosphamide for conditioning mice in stem cell transplant studies .
-
CML research: Models for chronic myeloid leukemia and bone marrow ablation.
-
Cell biology: Studies on DNA crosslink damage and repair.
-
In vivo dosing: Typically 100?mg/kg in animal models.
-
Pharmacokinetics: Short half-life (~2.5 hrs); hepatic metabolism; oral bioavailability ~80% .
Safety Profile & Side Effects
Common Research Observations
-
Hematologic suppression: leukopenia, thrombocytopenia, anemia
-
Pulmonary toxicity: potential fibrosis
-
Hepatotoxicity: elevated liver enzymes
-
Neurologic: seizures at high doses; anticonvulsant prophylaxis recommended
Handling & Storage Notes
-
Use PPE, handle under sterile conditions
-
Reconstitute and administer using aseptic technique
-
Dispose of waste as hazardous
-
Store vials refrigerated; protect from moisture and light
?? Research?Use Disclaimer
This product is intended for use only in laboratory research. Not approved for therapeutic, diagnostic, or veterinary uses. Misuse may pose serious risks or invalidate experimental results.
其他信息
| 重量 | 1.1 公斤 |
|---|---|
| 尺寸 | 18 × 16 × 18 厘米 |
相关产品
-
Ivodazumab Injection (lvonescimab) – 10?ml per Vial [For Laboratory Research Only]
Ivodazumab (Yidafang®) is a monoclonal antibody developed by Kangfang Pharmaceutical Co., Ltd., approved by China's NMPA (Approval No. S20240020; Drug Code: 86985204000011). Each vial contains 10?ml of the injectable formulation. Strictly for laboratory research use only—not for clinical or human use.
$1.00 -
Temozolomide Capsules 100?mg × 5 – ChuanNuo (MySean) | Research Grade Glioblastoma Drug
Temozolomide 100?mg capsules, 5?count box, produced by Shanghai ChuanNuo Pharmaceuticals Co., Ltd., approved under NMPA H20234716. A key alkylating agent for glioblastoma and astrocytoma research—ideal for preclinical oncology models.
?? For laboratory research or analytical use only – Not for human consumption or therapeutic use. $1.00 -
Mechlorethamine Hydrochloride Injection (HaiPu®) – 1?mL:5?mg Vial Price Comparison
Mechlorethamine hydrochloride (HaiPu®) is a potent DNA-alkylating agent from the nitrogen mustard class, supplied as a 1?mL vial containing 5?mg. Manufactured by Shanghai Xudong Haipu Pharmaceutical Co., Ltd., with NMPA approval H31020897 and product code 86900808000625. Strictly for laboratory research use.?Please consult the staff for other purposes? $1.00 -
Limertinib Tablets 80?mg ×?20 – by Osscon Pharma | Research Use Only (3rd?Gen EGFR?TKI)
Limertinib (OuyiXin®) is a third-generation EGFR tyrosine kinase inhibitor (EGFR?TKI) at 80?mg per tablet, 20 tablets per box, from Jiangsu Osscon Pharmaceutical. Approved by China’s NMPA under H20250004, it targets EGFR T790M?mutated non?small cell lung cancer, including patients with brain metastases.
?? For research use only – Not for human consumption or therapeutic use. $1.00
评价
目前还没有评价